BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rakesh Dachineni, D. Ramesh Kumar, Eduardo Callegari, Siddharth S. Kesharwani, Ranjini Sankaranarayanan, Teresa Seefeldt, Hemachand Tummala, G. Jayarama Bhat. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancerInternational Journal of Oncology 2017; 51(6): 1661 doi: 10.3892/ijo.2017.4167
2
Xiaohong Ruby Xu, George M. Yousef, Heyu Ni. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agentsBlood 2018; 131(16): 1777 doi: 10.1182/blood-2017-05-743187
3
Xiao-Nv Xie, Jing Yu, Li-Hua Zhang, Zhi-Ying Luo, Dong-Sheng Ouyang, Ling-Jie Zheng, Chun-Yang Wang, Li Yang, Ling Chen, Zhi-Rong Tan. Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese populationFunctional & Integrative Genomics 2019; 19(2): 227 doi: 10.1007/s10142-018-0642-8
4
Yue Guo, Yue Liu, Chengyue Zhang, Zheng-Yuan Su, Wenji Li, Mou-Tuan Huang, Ah-Ng Kong. The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 miceCarcinogenesis 2016; 37(6): 616 doi: 10.1093/carcin/bgw042
5
Octav Ginghina, Cornelia Nitipir. Colorectal Cancer - Diagnosis, Screening and Management2018;  doi: 10.5772/intechopen.72701
6
NaNa Keum, Edward L. Giovannucci. Pathology and Epidemiology of Cancer2017; : 391 doi: 10.1007/978-3-319-35153-7_21
7
Suaka Kagbo-Kue, Taiwo Ajose, Nicolas Bakinde. Aspirin inhibited the metastasis of colon cancer cells by inhibiting the expression of toll-like receptor 4Cell & Bioscience 2018; 8(1) doi: 10.1186/s13578-018-0234-2
8
Simone Mocellin, Annabel Goodwin, Sandro Pasquali. Risk-reducing medications for primary breast cancer: a network meta-analysisCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD012191.pub2
9
Olivier Fortin, Blanca Aguilar-Uscanga, Khanh Dang Vu, Stephane Salmieri, Monique Lacroix. Cancer Chemopreventive, Antiproliferative, and Superoxide Anion Scavenging Properties of Kluyveromyces marxianus and Saccharomyces cerevisiae var. boulardii Cell Wall ComponentsNutrition and Cancer 2018; 70(1): 83 doi: 10.1080/01635581.2018.1380204
10
Jun Li, Gary A. Cameron, Heather M. Wallace. Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cellsAmino Acids 2016; 48(4): 1003 doi: 10.1007/s00726-015-2143-6
11
Chen Sun, Fu-Jing Wang, Hao-Gang Zhang, Xun-Zheng Xu, Rui-Chun Jia, Lei Yao, Peng-Fei Qiao. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy <i>via</i> transforming growth factor-&beta;/Smad4 pathwayWorld Journal of Gastroenterology 2017; 23(10): 1816-1827 doi: 10.3748/wjg.v23.i10.1816
12
Etheresia Pretorius, Sthembile Mbotwe, Douglas B. Kell. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbiditiesScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09860-4
13
Bei Li, Kaiming Su, Guang Yang, Yanmei Feng, Li Xia, Shankai Yin. Assessment of the Potential Ototoxicity of High-Dose Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, in RatsOtolaryngology–Head and Neck Surgery 2015; 152(6): 1108 doi: 10.1177/0194599815573702
14
Daniel Plano, Deepkamal N. Karelia, Manoj K. Pandey, Julian E. Spallholz, Shantu Amin, Arun K. Sharma. Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer AgentsJournal of Medicinal Chemistry 2016; 59(5): 1946 doi: 10.1021/acs.jmedchem.5b01503
15
Preeti Kanikarla-Marie, Michael Lam, David G. Menter, Scott Kopetz. Platelets, circulating tumor cells, and the circulomeCancer and Metastasis Reviews 2017; 36(2): 235 doi: 10.1007/s10555-017-9681-1
16
Simone Mocellin, Annabel Goodwin, Sandro Pasquali. Risk-reducing medication for primary breast cancer: a network meta-analysisCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD012191
17
Xiaoya Ma, Huabing Zhang, Xiang Xue, Yatrik M. Shah. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activityJournal of Biological Chemistry 2017; 292(41): 17046 doi: 10.1074/jbc.M117.805655
18
Yan Tian, Yu Xu, Huawei Wang, Ruo Shu, Liang Sun, Yujian Zeng, Fangyou Gong, Yi Lei, Kunhua Wang, Huayou Luo. Comprehensive analysis of microarray expression profiles of circRNAs and lncRNAs with associated co-expression networks in human colorectal cancerFunctional & Integrative Genomics 2019; 19(2): 311 doi: 10.1007/s10142-018-0641-9
19
Isidro Cortes-Ciriano, Daniel S Murrell, Gerard JP van Westen, Andreas Bender, Thérèse E Malliavin. Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modelingJournal of Cheminformatics 2015; 7(1) doi: 10.1186/s13321-014-0049-z
20
James R. Lawrence, Gwendoline J. Baxter, John R. Paterson. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient rootsMedical Hypotheses 2016; 94: 74 doi: 10.1016/j.mehy.2016.07.001
21
Shan Lu, Obinna N. Obianom, Yong Ai. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancerBioorganic & Medicinal Chemistry Letters 2018; 28(17): 2869 doi: 10.1016/j.bmcl.2018.07.032
22
B. Ahmetaj-Shala, A. Tesfai, C. Constantinou, R. Leszczynski, M.V. Chan, H. Gashaw, G. Galaris, S. Mazi, T.D. Warner, N.S. Kirkby, J.A. Mitchell. Pharmacological assessment of ibuprofen arginate on platelet aggregation and colon cancer cell killingBiochemical and Biophysical Research Communications 2017; 484(4): 762 doi: 10.1016/j.bbrc.2017.01.161
23
Etheresia Pretorius, Janette Bester, Natasha Vermeulen, Sajee Alummoottil, Prashilla Soma, Antoinette V Buys, Douglas B Kell. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnosticsCardiovascular Diabetology 2015; 14(1): 30 doi: 10.1186/s12933-015-0192-5
24
Yongguo Shi, Yangchen Liu, Jirong Wang, Ding Jie, Tian Yun, Wang Li, Lin Yan, Keming Wang, Jifeng Feng, Vinod Scaria. Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 ExpressionPLOS ONE 2015; 10(4): e0122679 doi: 10.1371/journal.pone.0122679
25
Mark A. Moyad. Prostate Cancer2016; : 169 doi: 10.1016/B978-0-12-800077-9.00020-7
26
George J. Tsioulias, Mae F. Go, Basil Rigas. NSAIDs and Colorectal Cancer Control: Promise and ChallengesCurrent Pharmacology Reports 2015; 1(5): 295 doi: 10.1007/s40495-015-0042-x
27
Yuxiang Sun, Hui Dai, Shaopeng Chen, Yajun Zhang, Tao Wu, Xianbin Cao, Guoping Zhao, An Xu, Jun Wang, Lijun Wu. Disruption of Chromosomal Architecture of cox2 Locus Sensitizes Lung Cancer Cells to RadiotherapyMolecular Therapy 2018; 26(10): 2456 doi: 10.1016/j.ymthe.2018.08.002
28
Hermann Brenner, Chen Chen. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary preventionBritish Journal of Cancer 2018; 119(7): 785 doi: 10.1038/s41416-018-0264-x
29
Agnieszka Blazejczyk, Diana Papiernik, Kseniia Porshneva, Joanna Sadowska, Joanna Wietrzyk. Endothelium and cancer metastasis: Perspectives for antimetastatic therapyPharmacological Reports 2015; 67(4): 711 doi: 10.1016/j.pharep.2015.05.014
30
Xiu-Fen Liu, Ji-Long Hao, Tian Xie, Om Prakash Pant, Cheng-Bo Lu, Cheng-Wei Lu, Dan-Dan Zhou. The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignanciesCell Proliferation 2018; 51(4): e12449 doi: 10.1111/cpr.12449
31
Nipun Choudhry, Ankita Kaushal. An overview of colorectral cancerApollo Medicine 2015; 12(3): 194 doi: 10.1016/j.apme.2015.07.015
32
Preeti Kanikarla-Marie, Michael Lam, Alexey V. Sorokin, Michael J. Overman, Scott Kopetz, David G. Menter. Platelet Metabolism and Other Targeted Drugs; Potential Impact on ImmunotherapyFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00107